Rhumbline Advisers Vigil Neuroscience, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$2.51 - $4.66 $38,566 - $71,600
-15,365 Reduced 85.58%
2,588 $10,000
Q1 2024

May 09, 2024
BUY
$2.68 - $3.63 $1,833 - $2,482
684 Added 3.96%
17,953 $61,000
Q4 2023

Feb 08, 2024
SELL
$2.97 - $8.6 $2,313 - $6,699
-779 Reduced 4.32%
17,269 $58,000
Q3 2023

Nov 09, 2023
BUY
$4.8 - $9.92 $8,112 - $16,764
1,690 Added 10.33%
18,048 $97,000
Q2 2023

Aug 08, 2023
BUY
$8.11 - $10.54 $132,663 - $172,413
16,358 New
16,358 $153,000

Others Institutions Holding VIGL

# of Institutions
53
Shares Held
27.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vigil Neuroscience, Inc.

VIGL Quotes by TradingView
  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $85.7M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email